Biovica International AB (publ) (STO:BIOVIC.B)
Sweden · Delayed Price · Currency is SEK 0.3480
-0.0110 (-3.06%)
Nov 2, 2026, 5:20 PM CET
Biovica International AB Market Cap
Biovica International AB has a market cap or net worth of 101.59 million as of November 2, 2026. It is the 41,082nd most valuable company in the world and the 593rd biggest in Sweden. Its market cap has decreased by 30.11% in one year.
Market Cap
101.59M
Enterprise Value
56.02M
Revenue
14.93M
Global Rank
Country Rank
#593 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since March 29, 2017, Biovica International AB's market cap has decreased from 210.00M to 101.59M, a decrease of -51.63%. That is a compound annual growth rate of -7.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 139.73M | 29.37% |
| Dec 30, 2025 | 108.01M | -44.77% |
| Dec 30, 2024 | 195.57M | -9.82% |
| Dec 29, 2023 | 216.86M | -41.83% |
| Dec 30, 2022 | 372.79M | -68.37% |
| Dec 30, 2021 | 1.18B | -18.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Simris Group AB (PUBL) | 163.32M |
| Diamyd Medical AB | 154.36M |
| Abera Bioscience AB | 140.62M |
| Xintela AB | 134.36M |
| Initiator Pharma | 133.14M |
| Alzinova AB | 112.04M |
| Active Biotech AB | 105.31M |
| OncoZenge AB | 85.84M |